A Refreshing Outlook - Consensus Reports on Arena Pharmaceuticals, Inc. and Eli Lilly and Company
(firmenpresse) - JAKARTA, INDONESIA -- (Marketwire) -- 09/06/12 -- Moments ago, introduced new coverage of Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) and Eli Lilly and Company (NYSE: LLY). Full outlook, analysis and consensus opinion is available to readers via the links below.
The consistent delivery of accurate analyses relies solely on two factors, namely: market awareness and industry insight. Recent market drivers include August's contraction of U.S. manufacturing activity, an upward surprise of 0.4% in seasonally-adjusted house prices and the unexpected decline in construction spending. When it comes to discovering the right edge at the right time, all these factors play into effect. For a deeper understanding of the mechanics behind these events and how it can affect your portfolio, please refer to our email newsletter delivered to your inbox.
Investors Alliance is releasing new coverage on Arena Pharmaceuticals, Inc. for its current position within the consumer durables sector. Arena Pharmaceuticals, Inc. (Arena) is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs that target G protein-coupled receptors (GPCRs), in four therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. A copy of this report featuring Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) is available at: .
Investors Alliance has released research on Eli Lilly and Company for its changing role within the consumer durables sector. Eli Lilly and Company discovers, develops, manufactures, and sells products, in one business segment, pharmaceutical products. The Company also has an animal health business segment. It manufactures and distributes its products through facilities in the United States, Puerto Rico, and 15 other countries. To access the full research report on Eli Lilly and Company (NYSE: LLY) we welcome investors to visit: .
What is Investors Alliance?
Imagine a community wherein investors and traders of all walks share both knowledge and experience... enabling a knowledge base vastly greater than the sum of its parts. By joining forces, the entire community experiences the wealth of information, insight and intuition into some of the best strategies available today.
Patricia Byers
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 06.09.2012 - 13:00 Uhr
Sprache: Deutsch
News-ID 180968
Anzahl Zeichen: 0
contact information:
Town:
JAKARTA, INDONESIA
Kategorie:
Commercial & Investment Banking
Diese Pressemitteilung wurde bisher 126 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"A Refreshing Outlook - Consensus Reports on Arena Pharmaceuticals, Inc. and Eli Lilly and Company"
steht unter der journalistisch-redaktionellen Verantwortung von
Investors Alliance (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
